CoreWeave Shorts Add 24% in a Week as Bears Rebuild

Short sellers added 24% to their position in CoreWeave over the past week, the most aggressive build since the stock's IPO cohort. ORTEX estimates 77.9 million shares short as of October 20, equal to 20.2% of the free float, up from 62.8 million a month ago, a 33% increase in borrowed shares over thirty days.

The short book has accelerated precisely as the stock has fallen. CRWV closed at $62.13 on October 20, down 20% on the week and 24% over the past month. The daily increment on October 20 alone was 6.8%, the largest single-day addition in the ORTEX history shown. Bears who built earlier in September at prices near $90 have seen the trade move sharply in their favour, yet rather than reducing, the position is growing. The borrow market tells a more nuanced story: cost to borrow is 0.47%, effectively unchanged and still very cheap. Borrow availability has tightened considerably, dropping from 316% in mid-September to 107% now, meaning roughly one share remains available for every one already lent out. That is the tightest reading of the past six weeks, but not yet in territory that would force covering. The peer group is moving in the same direction: SHAZ fell 22% on the week, BRUN dropped 26%, and DOCN lost 22%, confirming this is a sector-wide repricing, not a CRWV-specific blow-up.

Options traders have moved to their most defensive stance since late September. The put/call ratio is 0.88, nearly two standard deviations above its 20-day average of 0.75, and close to the 52-week high of 1.00. This is the highest defensive reading since a brief spike on September 28. Taken together with the short-interest build, positioning on both sides of the market has turned more cautious in the same week.

The Street is recalibrating rather than capitulating. Goldman Sachs upgraded CRWV to Buy on October 19, setting a $106 target, making it the most meaningful bullish action of the week. But the upgrade sits below where the stock was trading two weeks ago, and Goldman's simultaneous target reset from $139 frames this as a valuation reset, not a conviction call. Piper Sandler, also this week, cut its target from $153 to $124 while keeping its Overweight rating. Mizuho trimmed to $88, and HSBC held its Reduce rating at $39. The consensus remains Buy, with 23 buys and 7 holds, and the mean price target of $138 implies more than 100% upside from current levels. That gap is either an opportunity or a sign that targets have not yet fully adjusted to the new price reality. The bear case rests on customer concentration, with Microsoft accounting for roughly 67% of 2025 revenue, and net debt running at 81% of market cap, with EBITDA covering interest expense by only 2.2x. The bull case is scarce GPU capacity, two rounds of price increases, and a first-mover position on new Nvidia hardware.

Institutional flows add another layer. BlackRock added 14.7 million shares in the quarter to September 30, one of the largest additions among top holders. Vanguard's active arm added 3.7 million shares over the same period. Those are significant buys against the backdrop of a stock falling 24%. Founder-level holders have been moving the other way: CEO Michael Intrator's last reported holding fell by 4 million shares in the September quarter, and Chief Strategy Officer Brian Venturo trimmed by 1.9 million. All recent insider open-market sales by the CFO and Chief Revenue Officer were executed under pre-arranged 10b5-1 plans, which reduces their signal value, but the net 90-day insider flow is negative, totalling roughly $54 million in net sales.

CoreWeave reports on November 12. The prior print, in August, produced a 22% single-day gain. The one before that moved less than 1% on the day but 18% over the following five sessions. With short interest at a new high, availability tightening, and a consensus target that sits more than double the current price, the gap between what bears and buyers believe about this company will start to close, or widen further, on that date.